Breaking

Syria is free of its dictator. The rebels’ biggest challenge now is learning how to govern
Israel bombs Syria and seizes territory as Netanyahu pledges to change ‘the face’ of the Middle East
South Korea’s ex-defense minister is formally arrested over martial law imposition
Drone strikes UN vehicle on way to inspect Ukrainian nuclear plant
Millions of ‘cloud trees’ are being planted in the Andes
Greyhound racing is increasingly rare worldwide. New Zealand now plans to outlaw the practice
South Korea’s former Defense Minister attempts to take his own life, official says, amid martial law political crisis
Vandals attack Jewish area in Sydney in latest antisemitic attack

Business
World
Politics
Investing
Search for:

Investing

Completion of preclinical data package for RAD 402

December 10, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

RETRANSMISSION: Grande Portage Completes Non-Brokered Private Placement

December 11, 2024

Troy Minerals Submits Drilling Permit Application for Table Mountain Silica Project, British Columbia

December 11, 2024

Crypto Market Forecast: Top Trends That Will Affect Crypto in 2025

December 11, 2024

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,085)
- Investing (2,234)
- Politics (3,145)
- World (3,075)

Disclaimer: RiskManagementMasters.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2024 RiskManagementMasters.com | All Rights Reserved

Top

Business
World
Politics
Investing

Type above and press Enter to search. Press Esc to cancel.